Does CILTACABTAGENE AUTOLEUCEL Cause Disease progression? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Disease progression have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 1.3% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
49
Reports of Disease progression with CILTACABTAGENE AUTOLEUCEL
1.3%
of all CILTACABTAGENE AUTOLEUCEL reports
12
Deaths
8
Hospitalizations
How Dangerous Is Disease progression From CILTACABTAGENE AUTOLEUCEL?
Of the 49 reports, 12 (24.5%) resulted in death, 8 (16.3%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Disease progression Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE